Betahistine Mesylate (e.q. Betahistine Dimesilate) contains not less than 98.0% and not more than 101.0% of C10H20N2O6S2, calculated on the anhydrous substance.

申請商
宇直泰貿易股份有限公司 
適應症
治療梅尼艾氏症候群所引起之眩暈、聽力障礙。
含量
0